XTX Topco’s Turnstone Biologics TSBX Stock Holding History

XTX Topco’s Portfolio TSBX Stock Details TSBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-40,401	Closed	–	–	3810
2025 Q3	$0	Buy	40,401 +2,615	+7%	+$937	﹤0.01%	3294
2025 Q2	$13.6K	Buy	37,786 +2,045	+6%	+$717	﹤0.01%	2213
2025 Q1	$14.7K	Buy	35,741 +23,982	+204%	+$10.2K	﹤0.01%	2198
2024 Q4	$5.82K	Buy	+11,759	New	+$5.81K	﹤0.01%	2188

XTX Topco's TSBX Position: Q4 2025 in Review

XTX Topco sold out of Turnstone Biologics (TSBX) in Q4 2025, closing a stake of 40,401 shares.

XTX Topco first reported a position in TSBX in Q4 2024 and held it in 4 quarters. The position peaked at $14.7K in Q1 2025. 0 funds tracked by Wall St. Rank hold TSBX as of Q4 2025.

XTX Topco reported no remaining Turnstone Biologics position as of Q4 2025 after selling out during the quarter.
XTX Topco sold 40,401 Turnstone Biologics shares in Q4 2025.
XTX Topco first reported a position in Turnstone Biologics in Q4 2024 and held it in 4 quarters.
XTX Topco's Turnstone Biologics position peaked at $14.7K in Q1 2025.
0 funds tracked by Wall St. Rank held Turnstone Biologics as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.